Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Clinical Gastroenterology and Hepatology Année : 2019

Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms

Résumé

Patient-reported outcomes (PRO) come directly from a patient about their health condition or impact of its treatments without interpretation by health care providers. Measures of disease activity in ulcerative colitis (UC) traditionally have included a combination of PROs (rectal bleeding [RB] and stool frequency [SF]), physician-assessed patient-based outcomes (physician global assessment), and objective measures of disease activity (endoscopic mucosal healing [MH]). These often are assessed using the Mayo score, and have formed the basis of all phase 3 clinical trial end points for drug approval and labeling claims.

Dates et versions

hal-02549567 , version 1 (21-04-2020)

Identifiants

Citer

Parambir Dulai, Laurent Peyrin-Biroulet. Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms. Clinical Gastroenterology and Hepatology, 2019, 17 (3), pp.395-396. ⟨10.1016/j.cgh.2018.08.060⟩. ⟨hal-02549567⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More